BioWorld - Friday, December 26, 2025
To read the full story, subscribe or sign in.
Musculoskeletal
Alebund Pharmaceuticals discovers new complement factor B inhibitors
Dec. 2, 2025
Alebund Pharmaceuticals (Hong Kong) Ltd. has described complement factor B (CFB) inhibitors reported to be useful for the treatment of glomerular disorders and rheumatoid arthritis.
BioWorld ScienceMusculoskeletalPatents